PTC Therapeutics, Inc. (PTCT)
70.00
-2.14
(-2.97%)
USD |
NASDAQ |
Feb 11, 11:06
PTC Therapeutics Shareholders Equity (Quarterly) : -155.76M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 1.320B |
| Spyre Therapeutics, Inc. | 455.10M |
| Keros Therapeutics, Inc. | 703.58M |
| ACADIA Pharmaceuticals, Inc. | 917.27M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.644B |
| Total Liabilities (Quarterly) | 2.799B |
| Debt to Equity Ratio | -2.633 |
| Current Ratio | 2.318 |
| Net Debt Paydown Yield | -0.06% |